49
Views
18
CrossRef citations to date
0
Altmetric
Review

Ocular adnexal non-Hodgkin’s lymphoma: a review of epidemiology and risk factors

, , &
Pages 181-193 | Published online: 09 Jan 2014

References

  • American Cancer Society: Cancer Facts and Figures 2010. American Cancer Society, Atlanta, GA, USA (2010).
  • Krol AD, le Cessie S, Snijder S, Kluin-Nelemans JC, Kluin PM, Noordijk EM. Primary extranodal non-Hodgkin’s lymphoma (NHL): the impact of alternative definitions tested in the Comprehensive Cancer Centre West population-based NHL registry. Ann. Oncol.14(1), 131–139 (2003).
  • Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer29(1), 252–260 (1972).
  • Fung CY, Tarbell NJ, Lucarelli MJ et al. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes. Int. J. Radiat. Oncol. Biol. Phys.57(5), 1382–1391 (2003).
  • Sasai K, Yamabe H, Dodo Y, Kashii S, Nagata Y, Hiraoka M. Non-Hodgkin’s lymphoma of the ocular adnexa. Acta Oncol.40(4), 485–490 (2001).
  • Margo CE, Mulla ZD. Malignant tumors of the orbit. Analysis of the Florida Cancer Registry. Ophthalmology105(1), 185–190 (1998).
  • Choi JY, Kafkala C, Foster CS. Primary intraocular lymphoma: a review. Semin. Ophthalmol.21(3), 125–133 (2006).
  • Gerstner ER, Batchelor TT. Primary central nervous system lymphoma. Arch. Neurol.67(3), 291–297 (2010).
  • Neudorfer M, Kessler A, Anteby I, Goldenberg D, Barak A. Co-existence of intraocular and orbital lymphoma. Acta Ophthalmol. Scand.82(6), 754–761 (2004).
  • Rootman JCW, Jones D. Distribution and differential diagnosis of orbital disease. In: Diseases of the Orbit. Rootman JCW (Ed.). Lippincott Williams and Wilkins, PA, USA, 53–85, 136–142 (2003).
  • Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the Committee on Hodgkin’s disease staging classification. Cancer Res.31(11), 1860–1861 (1971).
  • Musshoff K. [Clinical staging classification of non-Hodgkin’s lymphomas]. Strahlentherapie153(4), 218–221 (1977).
  • Coupland SE, White VA, Rootman J, Damato B, Finger PT. A TNM-based clinical staging system of ocular adnexal lymphomas. Arch. Pathol. Lab. Med.133(8), 1262–1267 (2009).
  • Harris NL, Jaffe ES, Stein H et al. A revised European–American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood84(5), 1361–1392 (1994).
  • Jaffe ES, Harris NL, Diebold J, Muller-Hermelink HK. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Am. J. Clin. Pathol.111(Suppl. 1), S8–S12 (1999).
  • Vardiman JW, Thiele J, Arber DA et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood114(5), 937–951 (2009).
  • Auw-Haedrich C, Coupland SE, Kapp A, Schmitt-Graff A, Buchen R, Witschel H. Long term outcome of ocular adnexal lymphoma subtyped according to the REAL classification. Revised European and American Lymphoma. Br. J. Ophthalmol.85(1), 63–69 (2001).
  • Rosado MF, Byrne GE Jr, Ding F et al. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci.Blood107(2), 467–472 (2006).
  • Coupland SE, Krause L, Delecluse HJ et al. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases. Ophthalmology105(8), 1430–1441 (1998).
  • Cho EY, Han JJ, Ree HJ et al. Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone B cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients. Am. J. Hematol.73(2), 87–96 (2003).
  • White WL, Ferry JA, Harris NL, Grove AS Jr. Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology102(12), 1994–2006 (1995).
  • Cahill M, Barnes C, Moriarty P, Daly P, Kennedy S. Ocular adnexal lymphoma-comparison of MALT lymphoma with other histological types. Br. J. Ophthalmol.83(6), 742–747 (1999).
  • Ohtsuka K, Hashimoto M, Suzuki Y. High incidence of orbital malignant lymphoma in Japanese patients. Am. J. Ophthalmol.138(5), 881–882 (2004).
  • Cheng CY, Hsu WM. Incidence of eye cancer in Taiwan: an 18-year review. Eye (Lond.)18(2), 152–158 (2004).
  • Coupland SE, Hummel M, Stein H. Ocular adnexal lymphomas: five case presentations and a review of the literature. Surv. Ophthalmol.47(5), 470–490 (2002).
  • Ferry JA, Fung CY, Zukerberg L et al. Lymphoma of the ocular adnexa: a study of 353 cases. Am. J. Surg. Pathol.31(2), 170–184 (2007).
  • Minehan KJ, Martenson JA Jr, Garrity JA et al. Local control and complications after radiation therapy for primary orbital lymphoma: a case for low-dose treatment. Int. J. Radiat. Oncol. Biol. Phys.20(4), 791–796 (1991).
  • Du MQ. MALT lymphoma: recent advances in aetiology and molecular genetics. J. Clin. Exp. Hematop.47(2), 31–42 (2007).
  • Harris NL, Jaffe ES, Diebold J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting – Airlie House, Virginia, November 1997. J. Clin. Oncol.17(12), 3835–3849 (1999).
  • Sharara N, Holden JT, Wojno TH, Feinberg AS, Grossniklaus HE. Ocular adnexal lymphoid proliferations: clinical, histologic, flow cytometric, and molecular analysis of forty-three cases. Ophthalmology110(6), 1245–1254 (2003).
  • Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood107(8), 3034–3044 (2006).
  • Groves FD, Linet MS, Travis LB, Devesa SS. Cancer surveillance series: non-Hodgkin’s lymphoma incidence by histologic subtype in the United States from 1978 through 1995. J. Natl Cancer Inst.92(15), 1240–1251 (2000).
  • Devesa SS, Fears T. Non-Hodgkin’s lymphoma time trends: United States and international data. Cancer Res.52(Suppl. 19), 5432s–5440s (1992).
  • Moslehi R, Coles FB, Schymura MJ. Descriptive epidemiology of ophthalmic and ocular adnexal non-Hodgkin’s lymphoma. Expert Rev. Ophthalmol.6(2), 175–180 (2011).
  • Gail MH, Pluda JM, Rabkin CS et al. Projections of the incidence of non-Hodgkin’s lymphoma related to acquired immunodeficiency syndrome. J. Natl Cancer Inst.83(10), 695–701 (1991).
  • Hartge P, Devesa SS. Quantification of the impact of known risk factors on time trends in non-Hodgkin’s lymphoma incidence. Cancer Res.52(Suppl. 19), 5566s–5569s (1992).
  • Eltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi’s sarcoma and non-Hodgkin’s lymphoma incidence in the United States from 1973 through 1998. J. Natl Cancer Inst.94(16), 1204–1210 (2002).
  • Biggar RJ, Rabkin CS. The epidemiology of acquired immunodeficiency syndrome-related lymphomas. Curr. Opin. Oncol.4(5), 883–893 (1992).
  • Moslehi R, Devesa SS, Schairer C, Fraumeni JF Jr. Rapidly increasing incidence of ocular non-hodgkin lymphoma. J. Natl Cancer Inst.98(13), 936–939 (2006).
  • Sjo LD, Ralfkiaer E, Prause JU et al. Increasing incidence of ophthalmic lymphoma in Denmark from 1980 to 2005. Invest. Ophthalmol. Vis. Sci.49(8), 3283–3288 (2008).
  • Ko YH, Kim CW, Park CS et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European–American lymphoma. Cancer83(4), 806–812 (1998).
  • Shikishima K, Kawai K, Kitahara K. Pathological evaluation of orbital tumours in Japan: analysis of a large case series and 1379 cases reported in the Japanese literature. Clin. Exp. Ophthalmol.34(3), 239–244 (2006).
  • Ahmed S, Shahid RK, Sison CP, Fuchs A, Mehrotra B. Orbital lymphomas: a clinicopathologic study of a rare disease. Am. J. Med. Sci.331(2), 79–83 (2006).
  • Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992–2001. Blood107(1), 265–276 (2006).
  • Bardenstein DS. Ocular adnexal lymphoma: classification, clinical disease, and molecular biology. Ophthalmol. Clin. North Am.18(1), 187–197 (2005).
  • Pluda J, Yarchoan R. For HIV patients survival increases the risk of lymphoma. RNA53(11), 144 (1990).
  • Pluda JM, Yarchoan R, Jaffe ES et al. Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy. Ann. Intern. Med.113(4), 276–282 (1990).
  • Schachter J. Infectious Diseases. Gorbach S, Bartlett J, Blacklow N (Eds). WB Saunders Company, PA, USA (1992).
  • Smith KA, Bradley KK, Stobierski MG, Tengelsen LA. Compendium of measures to control Chlamydophila psittaci (formerly Chlamydia psittaci) infection among humans (psittacosis) and pet birds, 2005. J. Am. Vet. Med. Assoc.226(4), 532–539 (2005).
  • Telfer BL, Moberley SA, Hort KP et al. Probable psittacosis outbreak linked to wild birds. Emerg. Infect. Dis.11(3), 391–397 (2005).
  • Marlier D, Leroy C, Sturbois M, Delleur V, Poulipoulis A, Vindevogel H. Increasing incidence of megabacteriosis in canaries (Serinus canarius domesticus). Vet. J.172(3), 549–552 (2006).
  • Shen D, Yuen HK, Galita DA, Chan NR, Chan CC. Detection of Chlamydia pneumoniae in a bilateral orbital mucosa-associated lymphoid tissue lymphoma. Am. J. Ophthalmol.141(6), 1162–1163 (2006).
  • Chan CC, Shen D, Mochizuki M et al. Detection of Helicobacter pylori and Chlamydia pneumoniae genes in primary orbital lymphoma. Trans. Am. Ophthalmol. Soc.104, 62–70 (2006).
  • Ferreri AJ, Guidoboni M, Ponzoni M et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J. Natl Cancer Inst.96(8), 586–594 (2004).
  • Ferreri AJ, Ponzoni M, Guidoboni M et al. Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. J. Clin. Oncol.23(22), 5067–5073 (2005).
  • Ferreri AJ, Ponzoni M, Guidoboni M et al. Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: a multicenter prospective trial. J. Natl Cancer Inst.98(19), 1375–1382 (2006).
  • Ferreri AJ, Dolcetti R, Dognini GP et al. Chlamydophila psittaci is viable and infectious in the conjunctiva and peripheral blood of patients with ocular adnexal lymphoma: results of a single-center prospective case–control study. Int. J. Cancer123(5), 1089–1093 (2008).
  • Ponzoni M, Ferreri AJ, Guidoboni M et al. Chlamydia infection and lymphomas: association beyond ocular adnexal lymphomas highlighted by multiple detection methods. Clin. Cancer Res.14(18), 5794–5800 (2008).
  • Yoo C, Ryu MH, Huh J et al. Chlamydia psittaci infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea. Am. J. Hematol.82(9), 821–823 (2007).
  • Chanudet E, Zhou Y, Bacon CM et al. Chlamydia psittaci is variably associated with ocular adnexal MALT lymphoma in different geographical regions. J. Pathol.209(3), 344–351 (2006).
  • Husain A, Roberts D, Pro B, McLaughlin P, Esmaeli B. Meta-analyses of the association between Chlamydia psittaci and ocular adnexal lymphoma and the response of ocular adnexal lymphoma to antibiotics. Cancer110(4), 809–815 (2007).
  • Yakushijin Y, Kodama T, Takaoka I et al. Absence of chlamydial infection in Japanese patients with ocular adnexal lymphoma of mucosa-associated lymphoid tissue. Int. J. Hematol.85(3), 223–230 (2007).
  • de Cremoux P, Subtil A, Ferreri AJ et al. Re: evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J. Natl Cancer Inst.98(5), 365–366 (2006).
  • Gracia E, Froesch P, Mazzucchelli L et al. Low prevalence of Chlamydia psittaci in ocular adnexal lymphomas from Cuban patients. Leuk. Lymphoma48(1), 104–108 (2007).
  • Mulder MM, Heddema ER, Pannekoek Y et al. No evidence for an association of ocular adnexal lymphoma with Chlamydia psittaci in a cohort of patients from The Netherlands. Leuk. Res.30(10), 1305–1307 (2006).
  • Goebel N, Serr A, Mittelviefhaus H, Reinhard T, Bogdan C, Auw-Haedrich C. Chlamydia psittaci, Helicobacter pylori and ocular adnexal lymphoma – is there an association. The German experience. Leuk. Res.31(10), 1450–1452 (2007).
  • Vargas RL, Fallone E, Felgar RE et al. Is there an association between ocular adnexal lymphoma and infection with Chlamydia psittaci? The University of Rochester experience. Leuk. Res.30(5), 547–551 (2006).
  • Carugi A, Onnis A, Antonicelli G et al. Geographic variation and environmental conditions as cofactors in Chlamydia psittaci association with ocular adnexal lymphomas: a comparison between Italian and African samples. Hematol. Oncol.28(1), 20–26 (2010).
  • Schachter J. Chlamydia psittaci – ‘reemergence’ of a forgotten pathogen. N. Engl. J. Med.315(3), 189–191 (1986).
  • Lietman T, Dawson C, Osaki S. Ocular chlamydial infections. Int. Ophthalmol. Clin.38(4), 125–135 (1998).
  • Andrews BE, Major R, Palmer SR. Ornithosis in poultry workers. Lancet1(8221), 632–634 (1981).
  • Johnson FW, Matheson BA, Williams H et al. Abortion due to infection with Chlamydia psittaci in a sheep farmer’s wife. Br. Med. J. (Clin. Res. Ed.)290(6468), 592–594 (1985).
  • Wreghitt T. Chlamydial infection of the respiratory tract. Commun. Dis. Rep. CDR Rev.3(9), R119–R124 (1993).
  • Wreghitt TG, Barker CE, Treharne JD, Phipps JM, Robinson V, Buttery RB. A study of human respiratory tract chlamydial infections in Cambridgeshire 1986–1988. Epidemiol. Infect.104(3), 479–488 (1990).
  • Doglioni C, Wotherspoon AC, Moschini A, de Boni M, Isaacson PG. High incidence of primary gastric lymphoma in northeastern Italy. Lancet339(8797), 834–835 (1992).
  • Parsonnet J, Hansen S, Rodriguez L et al. Helicobacter pylori infection and gastric lymphoma. N. Engl. J. Med.330(18), 1267–1271 (1994).
  • Chan CC, Smith JA, Shen DF, Ursea R, LeHoang P, Grossniklaus HE. Helicobacter pylori (H. pylori) molecular signature in conjunctival mucosa-associated lymphoid tissue (MALT) lymphoma. Histol. Histopathol.19(4), 1219–1226 (2004).
  • Ferreri AJ, Ponzoni M, Viale E et al. Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications. Hematol. Oncol.24(1), 33–37 (2006).
  • Lee SB, Yang JW, Kim CS. The association between conjunctival MALT lymphoma and Helicobacter pylori.Br. J. Ophthalmol.92(4), 534–536 (2008).
  • Gruenberger B, Woehrer S, Troch M et al. Assessment of the role of hepatitis C, Helicobacter pylori and autoimmunity in MALT lymphoma of the ocular adnexa in 45 Austrian patients. Acta Oncol.47(3), 355–359 (2008).
  • Sjo NC, Foegh P, Juhl BR et al. Role of Helicobacter pylori in conjunctival mucosa-associated lymphoid tissue lymphoma. Ophthalmology114(1), 182–186 (2007).
  • Daibata M, Komatsu T, Taguchi H. Human herpesviruses in primary ocular lymphoma. Leuk. Lymphoma37(3–4), 361–365 (2000).
  • Chan CC. Molecular pathology of primary intraocular lymphoma. Trans. Am. Ophthalmol. Soc.101, 275–292 (2003).
  • Ferreri AJ, Ernberg I, Copie-Bergman C. Infectious agents and lymphoma development: molecular and clinical aspects. J. Intern. Med.265(4), 421–438 (2009).
  • Mittra RA, Pulido JS, Hanson GA, Kajdacsy-Balla A, Brummitt CF. Primary ocular Epstein–Barr virus-associated non-Hodgkin’s lymphoma in a patient with AIDS: a clinicopathologic report. Retina19(1), 45–50 (1999).
  • Shen DF, Herbort CP, Tuaillon N, Buggage RR, Egwuagu CE, Chan CC. Detection of Toxoplasma gondii DNA in primary intraocular B cell lymphoma. Mod. Pathol.14(10), 995–999 (2001).
  • Buggage RR. Ocular manifestations of human T cell lymphotropic virus type 1 infection. Curr. Opin. Ophthalmol.14(6), 420–425 (2003).
  • Kumar SR, Gill PS, Wagner DG, Dugel PU, Moudgil T, Rao NA. Human T-cell lymphotropic virus type I-associated retinal lymphoma. A clinicopathologic report. Arch. Ophthalmol.112(7), 954–959 (1994).
  • Kohno T, Uchida H, Inomata H, Fukushima S, Takeshita M, Kikuchi M. Ocular manifestations of adult T cell leukemia/lymphoma. A clinicopathologic study. Ophthalmology100(12), 1794–1799 (1993).
  • Lauer SA, Fischer J, Jones J, Gartner S, Dutcher J, Hoxie JA. Orbital T cell lymphoma in human T cell leukemia virus-I infection. Ophthalmology95(1), 110–115 (1988).
  • Ohba N, Matsumoto M, Sameshima M et al. Ocular manifestations in patients infected with human T-lymphotropic virus type I. Jpn J. Ophthalmol.33(1), 1–12 (1989).
  • Cacoub P, Poynard T, Ghillani P et al. Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment virus C. Arthritis Rheum.42(10), 2204–2212 (1999).
  • Hermine O, Lefrere F, Bronowicki JP et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N. Engl. J. Med.347(2), 89–94 (2002).
  • Ramos-Casals M, Trejo O, Garcia-Carrasco M et al. Triple association between hepatitis C virus infection, systemic autoimmune diseases, and B cell lymphoma. J. Rheumatol.31(3), 495–499 (2004).
  • Waters L, Stebbing J, Mandalia S et al. Hepatitis C infection is not associated with systemic HIV-associated non-Hodgkin’s lymphoma: a cohort study. Int. J. Cancer116(1), 161–163 (2005).
  • Ferreri AJ, Viale E, Guidoboni M et al. Clinical implications of hepatitis C virus infection in MALT-type lymphoma of the ocular adnexa. Ann. Oncol.17(5), 769–772 (2006).
  • Arnaud P, Escande MC, Lecuit M et al. Hepatitis C virus infection and MALT-type ocular adnexal lymphoma. Ann. Oncol.18(2), 400–401; author reply 401–403 (2007).
  • Morgensztern D, Rosado M, Silva O et al. Prevalence of hepatitis C infection in patients with non-Hodgkin’s lymphoma in South Florida and review of the literature. Leuk. Lymphoma45(12), 2459–2464 (2004).
  • Rivero ME, Kuppermann BD, Wiley CA et al. Acquired immunodeficiency syndrome-related intraocular B cell lymphoma. Arch. Ophthalmol.117(5), 616–622 (1999).
  • Ormerod LD, Puklin JE. AIDS-associated intraocular lymphoma causing primary retinal vasculitis. Ocul. Immunol. Inflamm.5(4), 271–278 (1997).
  • Schanzer MC, Font RL, O’Malley RE. Primary ocular malignant lymphoma associated with the acquired immune deficiency syndrome. Ophthalmology98(1), 88–91 (1991).
  • Chan CC, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr. Opin. Ophthalmol.13(6), 411–418 (2002).
  • American Public Health Association. Control of Communicable Diseases Manual: an Official Report of the American Public Health Association. American Public Health Association, Washington, DC, USA (1995).
  • Ekstrom-Smedby K. Epidemiology and etiology of non-Hodgkin lymphoma – a review. Acta Oncol.45(3), 258–271 (2006).
  • Martin D, Gutkind JS. Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene27(Suppl. 2), S31–S42 (2008).
  • Du MQ, Isaccson PG. Gastric MALT lymphoma: from aetiology to treatment. Lancet Oncol.3(2), 97–104 (2002).
  • Zucca E, Cavalli F. Are antibiotics the treatment of choice for gastric lymphoma? Curr. Hematol. Rep.3(1), 11–16 (2004).
  • Verma V, Shen D, Sieving PC, Chan CC. The role of infectious agents in the etiology of ocular adnexal neoplasia. Surv. Ophthalmol.53(4), 312–331 (2008).
  • Jamesone PC. Textbook of Ophthalmology. Duke-Elder S (Ed.). Mosby, MO, USA (1954).
  • Hyjek E, Isaacson PG. Primary B cell lymphoma of the thyroid and its relationship to Hashimoto’s thyroiditis. Hum. Pathol.19(11), 1315–1326 (1988).
  • Royer B, Cazals-Hatem D, Sibilia J et al. Lymphomas in patients with Sjogren’s syndrome are marginal zone B cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses. Blood90(2), 766–775 (1997).
  • Friedman JA, Miller EB, Green L, Huszar M, Schattner A. A community-based cohort of 201 consecutive patients with primary Sjogren’s syndrome in Israel: Ashkenazi patients compared with those of Sephardic descent. Clin. Exp. Rheumatol.24(3), 274–280 (2006).
  • Voulgarelis M, Dafni UG, Isenberg DA, Moutsopoulos HM. Malignant lymphoma in primary Sjogren’s syndrome: a multicenter, retrospective, clinical study by the European Concerted Action on Sjogren’s Syndrome. Arthritis Rheum.42(8), 1765–1772 (1999).
  • Stark JJ, Newsom RW, Roman J, LaRocque JC, Richardson DW. Orbital MALT lymphoma in a patient with Graves’ ophthalmopathy: a unique observation. Cancer Invest.23(7), 593–595 (2005).
  • Ekstrom K, Hjalgrim H, Brandt L et al. Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives. Arthritis Rheum.48(4), 963–970 (2003).
  • Alexander DD, Mink PJ, Adami HO et al. The non-Hodgkin lymphomas: a review of the epidemiologic literature. Int. J. Cancer120(Suppl. 12), S1–S39 (2007).
  • Green PH, Fleischauer AT, Bhagat G, Goyal R, Jabri B, Neugut AI. Risk of malignancy in patients with celiac disease. Am. J. Med.115(3), 191–195 (2003).
  • Card TR, West J, Holmes GK. Risk of malignancy in diagnosed coeliac disease: a 24-year prospective, population-based, cohort study. Aliment Pharmacol. Ther.20(7), 769–775 (2004).
  • Pettersson T, Pukkala E, Teppo L, Friman C. Increased risk of cancer in patients with systemic lupus erythematosus. Ann. Rheum. Dis.51(4), 437–439 (1992).
  • Gronbaek K, D’Amore F, Schmidt K. Autoimmune phenomena in non-Hodgkin’s lymphoma. Leuk. Lymphoma18(3–4), 311–316 (1995).
  • Kubota T, Moritani S. High incidence of autoimmune disease in Japanese patients with ocular adnexal reactive lymphoid hyperplasia. Am. J. Ophthalmol.144(1), 148–149 (2007).
  • Omoti CE, Omoti AE. Richter syndrome: a review of clinical, ocular, neurological and other manifestations. Br. J. Haematol.142(5), 709–716 (2008).
  • Aboulafia DM, Pantanowitz L, Dezube BJ. AIDS-related non-Hodgkin lymphoma: still a problem in the era of HAART. AIDS Read.14(11), 605–617 (2004).
  • Andreone P, Gramenzi A, Lorenzini S et al. Posttransplantation lymphoproliferative disorders. Arch. Intern. Med.163(17), 1997–2004 (2003).
  • Dotti G, Fiocchi R, Motta T et al. Epstein–Barr virus-negative lymphoproliferate disorders in long-term survivors after heart, kidney, and liver transplant. Transplantation69(5), 827–833 (2000).
  • Chan SM, Hutnik CM, Heathcote JG, Orton RB, Banerjee D. Iris lymphoma in a pediatric cardiac transplant recipient: clinicopathologic findings. Ophthalmology107(8), 1479–1482 (2000).
  • Johnson BL. Intraocular and central nervous system lymphoma in a cardiac transplant recipient. Ophthalmology99(6), 987–992 (1992).
  • Rizkalla K, Rodrigues S, Proulx A, Tingey DP, Heathcote JG. Primary intraocular lymphoma arising during methotrexate treatment of temporal arteritis. Can. J. Ophthalmol.40(5), 585–592 (2005).
  • Loves SS, de Haan L, Daenen SM. Familial aggregation of non-Hodgkin’s lymphoma (NHL). A case report. Hered. Cancer Clin. Pract.4(3), 136–139 (2006).
  • Chang ET, Smedby KE, Hjalgrim H et al. Family history of hematopoietic malignancy and risk of lymphoma. J. Natl Cancer Inst.97(19), 1466–1474 (2005).
  • Altieri A, Bermejo JL, Hemminki K. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database. Blood106(2), 668–672 (2005).
  • Rothman N, Skibola CF, Wang SS et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol.7(1), 27–38 (2006).
  • Rollinson S, Levene AP, Mensah FK et al. Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood102(3), 1007–1011 (2003).
  • Dinarello CA. Biologic basis for interleukin-1 in disease. Blood87(6), 2095–2147 (1996).
  • Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology61(3), 154–166 (2000).
  • Zucca E, Conconi A, Pedrinis E et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood101(7), 2489–2495 (2003).
  • Auer IA, Gascoyne RD, Connors JM et al. t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Ann. Oncol.8(10), 979–985 (1997).
  • Ott G, Katzenberger T, Greiner A et al. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin’s lymphomas of the mucosa-associated lymphoid tissue (MALT) type. Cancer Res.57(18), 3944–3948 (1997).
  • Wotherspoon AC, Pan LX, Diss TC, Isaacson PG. Cytogenetic study of B cell lymphoma of mucosa-associated lymphoid tissue. Cancer Genet. Cytogenet.58(1), 35–38 (1992).
  • Streubel B, Lamprecht A, Dierlamm J et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood101(6), 2335–2339 (2003).
  • Remstein ED, Kurtin PJ, James CD, Wang XY, Meyer RG, Dewald GW. Mucosa-associated lymphoid tissue lymphomas with t(11;18)(q21;q21) and mucosa-associated lymphoid tissue lymphomas with aneuploidy develop along different pathogenetic pathways. Am. J. Pathol.161(1), 63–71 (2002).
  • Schiby G, Polak-Charcon S, Mardoukh C et al. Orbital marginal zone lymphomas: an immunohistochemical, polymerase chain reaction, and fluorescence in situ hybridization study. Hum. Pathol.38(3), 435–442 (2007).
  • Streubel B, Simonitsch-Klupp I, Mullauer L et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia18(10), 1722–1726 (2004).
  • Remstein ED, Dogan A, Einerson RR et al. The incidence and anatomic site specificity of chromosomal translocations in primary extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in North America. Am. J. Surg. Pathol.30(12), 1546–1553 (2006).
  • Nakamura S, Ye H, Bacon CM et al. Clinical impact of genetic aberrations in gastric MALT lymphoma: a comprehensive analysis using interphase fluorescence in situ hybridisation. Gut56(10), 1358–1363 (2007).
  • Li BZ, Lu HF, Zhou XY et al. Frequency of genetic aberrations in mucosa-associated lymphoid tissue lymphoma of different sites. Zhonghua Bing Li Xue Za Zhi37(9), 604–608 (2008).
  • Dierlamm J, Baens M, Wlodarska I et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood93(11), 3601–3609 (1999).
  • Zhang Q, Siebert R, Yan M et al. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32). Nat. Genet.22(1), 63–68 (1999).
  • Tsai AG, Lu Z, Lieber MR. The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas is a CpG-type translocation, but the t(11;18)(q21;q21)/API2-MALT1 translocation in MALT lymphomas is not. Blood115(17), 3640–3641; author reply 3641–3642 (2010).
  • Sjo LD, Heegaard S, Prause JU, Petersen BL, Pedersen S, Ralfkiaer E. Extranodal marginal zone lymphoma in the ocular region: clinical, immunophenotypical, and cytogenetical characteristics. Invest. Ophthalmol. Vis. Sci.50(2), 516–522 (2009).
  • Dong LN, Liu HG, Jin HS et al. Primary ocular adnexal lymphoproliferative lesions: clinicopathologic features and genetic alterations. Zhonghua Bing Li Xue Za Zhi37(12), 809–814 (2008).
  • Kim WS, Honma K, Karnan S et al. Genome-wide array-based comparative genomic hybridization of ocular marginal zone B cell lymphoma: comparison with pulmonary and nodal marginal zone B cell lymphoma. Genes Chromosomes Cancer46(8), 776–783 (2007).
  • Nola M, Lukenda A, Bollmann M, Kalauz M, Petrovecki M, Bollmann R. Outcome and prognostic factors in ocular adnexal lymphoma. Croat. Med. J.45(3), 328–332 (2004).
  • Konoplev S, Lin P, Qiu X, Medeiros LJ, Yin CC. Clonal relationship of extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue involving different sites. Am. J. Clin. Pathol.134(1), 112–118 (2010).
  • Sugiyama T, Asaka M, Nakamura T, Nakamura S, Yonezumi S, Seto M. API2-MALT1 chimeric transcript is a predictive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma. Gastroenterology120(7), 1884–1885 (2001).
  • Alpen B, Neubauer A, Dierlamm J et al. Translocation t(11;18) absent in early gastric marginal zone B cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood95(12), 4014–4015 (2000).
  • Chanudet E, Ye H, Ferry J et al. A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands. J. Pathol.217(3), 420–430 (2009).
  • Novak U, Rinaldi A, Kwee I et al. The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood113(20), 4918–4921 (2009).
  • Dolcetti R, Ponzoni M, Ferreri AJ, Doglioni C. Genetic and epigenetic changes linked to Chlamydophila psittaci-associated ocular adnexal lymphomas. Hematol. Oncol.28(1), 1–2 (2010).
  • Maekita T, Nakazawa K, Mihara M et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer Res.12(3 Pt 1), 989–995 (2006).
  • Gottwein E, Mukherjee N, Sachse C et al. A viral microRNA functions as an orthologue of cellular miR-155. Nature450(7172), 1096–1099 (2007).
  • Samols MA, Skalsky RL, Maldonado AM et al. Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog.3(5), e65 (2007).
  • Stern-Ginossar N, Elefant N, Zimmermann A et al. Host immune system gene targeting by a viral miRNA. Science317(5836), 376–381 (2007).
  • Mlotshwa S, Pruss GJ, Vance V. Small RNAs in viral infection and host defense. Trends Plant Sci.13(7), 375–382 (2008).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.